The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
OPTIMA (Optimal Personalised Treatment of early breast cancer usIng Multi-parameter Analysis): A prospective trial to validate the predictive utility and cost-effectiveness of gene expression test-directed chemotherapy decisions.
 
Andreas Makris
No Relationships to Disclose
 
Luke Hughes-Davies
No Relationships to Disclose
 
Iain R. MacPherson
No Relationships to Disclose
 
Andrea Marshall
No Relationships to Disclose
 
Amy F. Campbell
No Relationships to Disclose
 
John Bartlett
Consulting or Advisory Role - BioNTech Diagnostics; Insight Genetics
 
Peter Hall
No Relationships to Disclose
 
David A. Cameron
No Relationships to Disclose
 
Leila Rooshenas
No Relationships to Disclose
 
Daniel Rea
No Relationships to Disclose
 
Helena Margaret Earl
No Relationships to Disclose
 
Christopher John Poole
Consulting or Advisory Role - Genomic Health
Speakers' Bureau - Genomic Health
 
Adele Francis
No Relationships to Disclose
 
Adrienne Morgan
No Relationships to Disclose
 
Sarah Pinder
Consulting or Advisory Role - Genomic Health
 
Claire Hulme
No Relationships to Disclose
 
Victoria Harmer
No Relationships to Disclose
 
Christopher McCabe
No Relationships to Disclose
 
Janet Dunn
No Relationships to Disclose
 
Robert C. Stein
Stock and Other Ownership Interests - GlaxoSmithKline
Consulting or Advisory Role - Syndax
Travel, Accommodations, Expenses - Amgen; Celgene